Acumen Research and Consulting has announced the addition of the “Molecular Diagnostics Market – Global Industry Size, Share, Trends, and Forecast, 2018 – 2026” report to their offering.
The Molecular Diagnostics Market – Global Industry Size, Share, Trends, and Forecast, 2018 – 2026 Industry Report 2018 is an in depth study analyzing the current state of the Molecular Diagnostics Market – Global Industry Size, Share, Trends, and Forecast, 2018 – 2026. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Molecular Diagnostics Market – Global Industry Size, Share, Trends, and Forecast, 2018 – 2026 provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Molecular Diagnostics Market – Global Industry Size, Share, Trends, and Forecast, 2018 – 2026 also discusses the opportunity areas for investors.
Download Sample Report Copy From Here @
https://www.acumenresearchandconsulting.com/request-sample/893
The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Report Coverage:
| Market | Molecular Diagnostics Market |
| Analysis Period | 2015 – 2026 |
| Historic Data | 2015 – 2016 |
| Base Year | 2017 |
| Forecast Data | 2018 – 2026 |
| Market Stratification | Product, Technology, application, End-User, Geography |
| Regional Scope | North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA) |
| Report Coverage | Market Trends, Drivers, Restraints, Porter’s Five Forces Analysis, Competitive Analysis, Player Profiling, Value Chain Analysis |
Market Players
The molecular diagnostics market comprises of some of the major players such as
- Abbott Molecular Cepheid
- BioMerieux’s
- Roche diagnostics
- Danaher Corporation
- Siemens Healthcare
- Qiagen Gaithersburg
- Johnson and Johnson
- Agilent (Dako)
- GenMark diagnostics
- Analytik Jena and Alere Inc.
Our expert team will assist and customize the report so that it best fit your exact requirement, Click Here@
https://www.acumenresearchandconsulting.com/request-customization/893
The major market segments of global Molecular Diagnostics Market – Global Industry Size, Share, Trends, and Forecast, 2018 – 2026 market are as below:
Market By Product
- Instruments
- Reagents
- Software & Services
Market By Technology
- Polymerase Chain Reactions (PCR)
- Hybridization
- DNA Sequencing
- Microarray
- Others
Market By Application
- Infectious Diseases
- Oncology
- Genetic Testing
- Blood Screening
- Others
Market By End-User
- Hospital
- Laboratories
- Others
Market By Geography
- North America
- US
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of MEA
Table Of Content:
1.1. Definition and Scope
1.1.1. Definition of Molecular Diagnostics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Molecular Diagnostics Market By Product
1.2.2.1. Global Molecular Diagnostics Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Molecular Diagnostics Market Revenue Share By Product in 2017
1.2.2.3. Instruments
1.2.2.4. Reagents
1.2.2.5. Software & Services
1.2.2.6. Others
1.2.3. Molecular Diagnostics Market By Technology
1.2.3.1. Global Molecular Diagnostics Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.3.2. Global Molecular Diagnostics Market Revenue Share By Technology in 2017
1.2.3.3. Polymerase Chain Reactions (PCR)
1.2.3.4. Hybridization
1.2.3.5. DNA Sequencing
1.2.3.6. Microarray
1.2.3.7. Others
1.2.4. Molecular Diagnostics Market By Application
1.2.4.1. Global Molecular Diagnostics Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. Global Molecular Diagnostics Market Revenue Share By Application in 2017
1.2.4.3. Infectious Diseases
1.2.4.4. Oncology
1.2.4.5. Genetic Testing
1.2.4.6. Blood Screening
1.2.4.7. Others
1.2.5. Molecular Diagnostics Market By End Users
1.2.5.1. Global Molecular Diagnostics Market Revenue and Growth Rate Comparison By End Users (2015-2026)
1.2.5.2. Global Molecular Diagnostics Market Revenue Share By End Users in 2017
1.2.5.3. Hospital
1.2.5.4. Laboratories
1.2.5.5. Others
1.2.6. Molecular Diagnostics Market by Geography
1.2.6.1. Global Molecular Diagnostics Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.6.2. North America Molecular Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.6.3. Europe Molecular Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.6.4. Asia-Pacific Molecular Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.6.5. Latin America Molecular Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.6.6. Middle East and Africa (MEA) Molecular Diagnostics Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Molecular Diagnostics Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Molecular Diagnostics Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Molecular Diagnostics Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Molecular Diagnostics Major Manufacturers in 2017
CHAPTER 4. Molecular Diagnostics MARKET BY PRODUCT
4.1. Global Molecular Diagnostics Revenue By Product
4.2. Instruments
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Reagents
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Software & Services
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Others
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 5. Molecular Diagnostics MARKET By Technology
5.1. Global Molecular Diagnostics Revenue By Technology
5.2. Polymerase Chain Reactions (PCR)
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Hybridization
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. DNA Sequencing
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.5. Microarray
5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.6. Others
5.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 6. Molecular Diagnostics MARKET By Application
6.1. Global Molecular Diagnostics Revenue By Application
6.2. Infectious Diseases
6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.3. Oncology
6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.4. Genetic Testing
6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.5. Blood Screening
6.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.6. Others
6.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 7. Molecular Diagnostics MARKET By End Users
7.1. Global Molecular Diagnostics Revenue By End Users
7.2. Hospital
7.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
7.3. Laboratories
7.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
7.4. Others
7.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 8. NORTH AMERICA Molecular Diagnostics MARKET BY COUNTRY
8.1. North America Molecular Diagnostics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. North America Molecular Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. U.S.
8.3.1. U.S. Molecular Diagnostics Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.5. Mexico
8.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
CHAPTER 9. EUROPE Molecular Diagnostics MARKET BY COUNTRY
9.1. Europe Molecular Diagnostics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Europe Molecular Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.6.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.7.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
CHAPTER 10. ASIA-PACIFIC Molecular Diagnostics MARKET BY COUNTRY
10.1. Asia-Pacific Molecular Diagnostics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Asia-Pacific Molecular Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.6.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.7.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.8.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
CHAPTER 11. LATIN AMERICA Molecular Diagnostics MARKET BY COUNTRY
11.1. Latin America Molecular Diagnostics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Latin America Molecular Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.4. Argentina
11.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
CHAPTER 12. MIDDLE EAST Molecular Diagnostics MARKET BY COUNTRY
12.1. Middle East Molecular Diagnostics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
12.2. Middle East Molecular Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. Saudi Arabia
12.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
12.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
12.4. UAE
12.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
12.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
12.5. Rest of Middle East
12.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
12.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
CHAPTER 13. AFRICA Molecular Diagnostics MARKET BY COUNTRY
13.1. Africa Molecular Diagnostics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
13.2. Africa Molecular Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
13.3. South Africa
13.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
13.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
13.4. Egypt
13.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
13.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
13.5. Rest of Africa
13.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
13.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
CHAPTER 14. COMPANY PROFILE
14.1. Abbott Molecular Cepheid
14.1.1. Company Snapshot
14.1.2. Overview
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. Key Developments
14.1.6. Strategies
14.2. BioMerieux’s
14.2.1. Company Snapshot
14.2.2. Overview
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. Key Developments
14.2.6. Strategies
14.3. Roche diagnostics
14.3.1. Company Snapshot
14.3.2. Overview
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. Key Developments
14.3.6. Strategies
14.4. Danaher Corporation
14.4.1. Company Snapshot
14.4.2. Overview
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. Key Developments
14.4.6. Strategies
14.5. Siemens Healthcare
14.5.1. Company Snapshot
14.5.2. Overview
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. Key Developments
14.5.6. Strategies
14.6. Qiagen Gaithersburg
14.6.1. Company Snapshot
14.6.2. Overview
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. Key Developments
14.6.6. Strategies
14.7. Johnson and Johnson
14.7.1. Company Snapshot
14.7.2. Overview
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. Key Developments
14.7.6. Strategies
14.8. Agilent (Dako)
14.8.1. Company Snapshot
14.8.2. Overview
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. Key Developments
14.8.6. Strategies
14.9. GenMark diagnostics
14.9.1. Company Snapshot
14.9.2. Overview
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. Key Developments
14.9.6. Strategies
14.10. Analytik Jena and Alere Inc.
14.10.1. Company Snapshot
14.10.2. Overview
14.10.3. Financial Overview
14.10.4. Product Portfolio
14.10.5. Key Developments
14.10.6. Strategies
14.11. Others
14.11.1. Company Snapshot
14.11.2. Overview
14.11.3. Financial Overview
14.11.4. Product Portfolio
14.11.5. Key Developments
14.11.6. Strategies
CHAPTER 15. RESEARCH APPROACH
15.1. Research Methodology
15.1.1. Initial Data Search
15.1.2. Secondary Research
15.1.3. Primary Research
15.2. Assumptions and Scope
Ask Query Here: frank@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Inquiry Before Buying@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/893
To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/893
